CME Group (CME) has drawn investor interest after recent trading in the stock, with a last close of $291.23 and a market value of about $105.5b, prompting a closer look at fundamentals.

Recent trading has been choppy, with the 7 day share price return down 4.55% and the 90 day share price return down 8.71%. However, the year to date share price return of 7.99% and a 3 year total shareholder return of 87.62% still point to longer term momentum.

If CME Group’s recent moves have you rethinking where opportunities might sit in the market, this is a good moment to scan 20 top founder-led companies

With CME Group trading around $291 and carrying a market value of about $105.5 billion, investors are asking a simple question: is this stock still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 5% Undervalued

At a last close of $291.23 versus a narrative fair value of $306.60, the most followed view sees modest upside that hinges on specific growth and margin assumptions.

The analysts have a consensus price target of $306.6 for CME Group based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $353.0, and the most bearish reporting a price target of just $230.0.

Curious what kind of revenue growth, earnings path and future P/E multiple are baked into that fair value, and how much share count creep is assumed.

Result: Fair Value of $306.60 (UNDERVALUED)

However, this hinges on several moving parts, including the risk that lower volatility or a shift toward DeFi venues could reduce trading volumes and fee revenue.

Another Angle on Valuation

While the analyst narrative suggests CME Group is about 5% undervalued at $291.23 versus a fair value of $306.60, the SWS DCF model points the other way, with an estimate of $248.63. This implies the stock is trading rich on this framework, so which lens do you trust more?

Next Steps

If the mixed signals around CME Group have you unsure, this is the moment to look through the data yourself and decide where you stand. To weigh up what investors see as the key upsides and the main concerns, take a close look at the 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If CME Group is already on your radar, do not stop there. Broaden your watchlist with other stock ideas that match your goals and risk comfort.

• Target potential value opportunities by scanning 48 high quality undervalued stocks that combine quality fundamentals with prices the market may not fully appreciate yet.
• Strengthen your income stream by reviewing 10 dividend fortresses that focus on higher yields supported by underlying cash flows.
• Dial down portfolio stress by checking 68 resilient stocks with low risk scores designed for investors who want steadier profiles and lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.